Catalog Number 07C18-29 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Type
malfunction
|
Manufacturer Narrative
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There is no further patient information provided by the customer.This report is being filed on an international product, list number 7c18 that has a similar product distributed in the us, list number 1l82.
|
|
Event Description
|
The customer reported a falsely elevated architect (b)(6) result on one patient.Results provided: (b)(6) = 600 miu/ml.The physician questioned the results due to no history of (b)(6) and (b)(6) vaccine not administered.Other test results provided: (b)(6) = 8 / 7.865 / 7.225 s/co; (b)(6) = negative.No impact to patient management was reported.
|
|
Manufacturer Narrative
|
The evaluation of complaint data for the product and likely cause lot 06339fn00 identified normal complaint activity and there are no trends for the product related to patient results.No customer returns were available for evaluation.A review of overall customer field data was performed to assess the performance of the architect anti-hbs assay and is within the established baselines confirming no systemic issues in the field.A review of the manufacturing documentation did not identify any issues associated with the customers observation.A review of labeling concluded that the issue is sufficiently addressed.No product deficiency was identified.
|
|
Search Alerts/Recalls
|